TN DCA Flashcards
What does the Board require as far as being able to dispense controlled substances? Is being a DEA registrant sufficient?
Shall obtain a registration issued by the board of pharmacy
Must each place of business register, or is one registration sufficient for multiple chain pharmacies, for example?
Separate registration is required at each principal place of business or professional practice
What does the TCA say about dispensing C-IIs without a written prescription? Is it allowed? If so, under what circumstances?
- No CIIs dispensed without electronic Rx except:
a. Emergency situations (defined by federal law)
b. Dispensed directly by prescriber to ultimate user
c. Exceptions covered under TCA 63-01-160
How many refills are authorized on C-III and C-IV medications? How about C-Vs? How long are prescriptions “good” or valid?
- CIII and CIV: no more than FIVE (5) refills
a. Rx good for SIX (6) months from date of issue - CV: ELEVEN (11) refills
a. Rx good for ONE (1) year from date of issue
What is the maximum amount of opioid medications that can be issued by a prescriber at one time? How about benzodiazepines? How about stimulants?
No limits on how many can be issued
What is the maximum amount of opioid medications that can be dispensed by a pharmacist at one time? How about benzodiazepines?
Opioids and BZD: Cannot dispense in quantities greater than a 30 days supply
What must a prescriber do if (s)he dispenses opioids, BZDs, carisoprodol, or barbiturates?
Submit to CSMD
What must a patient disclose to a prescriber specific to controlled substances previously received?
If the person has received either the same controlled substance or a controlled substance of similar therapeutic use from another practitioner within the previous thirty days
If a pharmacist has actual knowledge about a patient attempting to obtain controlled substances in an illegal manner, what steps is (s)he to take? When?
Submit a report to local enforcement within five (5) business days of obtaining such knowledge
What are the ID requirements when dispensing opioids, BZDs, zolpidem, barbiturates, or carisoprodol? When does the requirement apply? What if a patient is known to the pharmacist?
- Specific to CII, CIII, CIV opioids, benzos, zolpidem, barbiturates, and carisoprodol >7 day supply
a. Present valid government issued ID or insurance card (OR be personally known)
b. If homeless and/or a minor, use professional judgment
c. Excludes vet prescriptions, drug samples, inpatients, institutionalized, mail order, and home deliveries
Can buprenorphine tablets be prescribed for the treatment of pain in TN?
NO. This is an off-label use. In TN, this can only be prescribed for FDA-approved use which is opioid dependence
When can buprenorphine monotherapy be legally prescribed for patients with SUDs?
BUP only is limited to pregnant or nursing patients, having adverse rxn to naloxone, or direct admin by healthcare provider
Can NPs and PAs prescribe buprenorphine in TN? If so, what are the stipulations?
- If employed under a community mental health center or FQHC that employs 1 or more physicians who adopted clinical protocols for MAT
a. If facility takes TennCare pts
b. Max 4NP or 4PA per supervising physician
c. 100% chart review
d. Max 50 patients being prescribed BUP at any one time
e. No mono product; max dose: 16mg daily - If employed under nonresidential office-based opiate tx facility
a. Facility takes TennCare patients
b. Max of 2 NP/PA per physician
c. Max 100 pts being prescribed at any one time
d. No mono product; max dose 16mg daily
What are the requirements if a practitioner in TN is prescribing more than 16 mg/day of buprenorphine to a patient? More than 20 mg/day?
- > 16mg/day for 30+ consecutive days; requires documentation of need for high dose
- > 20mg/day for 30+ consecutive days; recommended addiction specialist consult
Can pharmacies sell (distribute) buprenorphine products to nonresidential office-based opiate treatment facilities? What reporting responsibilities does a pharmacy have?
Report to DOH the quantities of BUP that is delivered to nonresidential office-based opiate treatment facilities
What is the definition of “dispense”?
To deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery